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As an important tool for qualitative and quantitative analysis of 
proteins, mass spectrum (MS) has been popular in biological research since 
its emergence. Traditional data-dependent acquisition (DDA) MS can 
effectively operate qualitative analysis of proteins, but its 
repetitiveness and quantitative function are weak. Another method, 
selected reaction monitoring (SRM), though with high repetitiveness and 
quantitative accuracy, has been limited by its low flux. The recently 
developed SWATH MS can make up the defects of the two MS methods above. 
And as a date-independent MS technology, it draws the extensive attention 
of people. But current data analysis method of SWATH MS requires the 
addition of iRT peptide to the prepared samples before the identification. 
On the other hand, a characterized peptide library should be constructed 
before the analysis, which requires much time and energy, also limits the 
results with its capacity. Normally, when solving biological issues with 
MS, the researches must deal with multiple samples to find the differences 
in proteins. This thesis put forward a novel analysis method which could 
be used for analyzing data from data-independent acquisition MS, 
including SWATH MS. This method can identify peptides by calculating the 
virtual spectrum through comparison of the relativity between a mass 
spectrometry and two-stage mass spectrometry, which comes from peptides 
of different groups, and searching the database. It has higher accuracy 
of the virtual spectrum than previous methods, while has no need of a 
characterized peptide library. Furthermore, it can identify more peptides 
than OpenSWATH when analyzing the SWATH-MS standard database, with 
commendable quantitative accuracy. We can use this novel analysis method 
















necrosis factor (TNF)-stimulated L929 cells, with revealing of some 
unknown interactions. 
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